ICYMI, some of this week’s featured content includes an exclusive interview about tralokinumab, and articles on ruxolitinib as a treatment for vitiligo, the role of diet in acne and more.
A recent study in JAMA Dermatology investigated the possible association of atopic dermatitis and mental health outcomes across childhood.
How are atopic dermatitis and out of pocket health care expenses related? This study aimed to find out.
Nemolizumab phase 2 clinical trial data for patients with prurigo nodularis and atopic dermatitis was recently released at the EADV.
Amgen and Kyowa Kirin announce positive study data from their phase 2 trial of AMG 451/KHK4083.
In this month's Legal Eagle column, David J. Goldberg, MD, JD, addresses the question of what private practice dermatologist have to consider with Covid-19 vaccines.
In this exclusive video interview with Dermatology Times®, Andrew Blauvelt, MD, MBA, discusses the newest phase 3 clinical data on investigational tralokinumab as a potential treatment option in atopic dermatitis.
Arcutis Biotherapeutics, Inc has released data from its DERMIS-1 and DERMIS-2 Phase 3 pivotal studies demonstrating that the topical significantly reduced the burden and severity of itch.
The two companies are using their DREAM initiative to support the diverse dermatology index.
Researchers examine whether daylight PDT is less painful but equally as effective as conventional PDT as treatment for actinic keratosis.
A recent review evaluates the information provided to clinicians regarding antimicrobial resistance in impetigo treatment.
With increasing antibiotic resistance to treatment, impetigo research has been driven to find newer alternative options.
A recent study examines the role of a vegan or omnivore diet on photodynamic therapy for actinic keratosis.
In this month's Cosmetic Conundrums column, Dermatology Times® Chief Medical Editor Zoe Diana Draelos, MD, explore skin and hair diversity, including physiological and characteristic differences.
Coppertone, David Light, founder and CEO of Valisure, and Christopher Bunick, MD, PhD, share their thoughts on the sunscreen giant’s voluntary recall of 12 lots of its aerosol sunscreen after finding the presence of benzene.
Bayer is recalling its Lotrimin AF and Tinactin spray products due to the presence of the carcinogen benzene.
In this week’s Pointers with Dr Portela, the 208SkinDoc watches several TikTok videos in which creators share their experience with hidradenitis suppurativa.
The European Medicines Agency has validated its marketing authorization application for the fixed-dose combination of relatlimab and nivolumab in the frontline treatment of adult and pediatric patients with advanced melanoma.
A recent study examines systemic and phototherapy treatment utilization and drug survival in pediatric patients with psoriasis.
There wasn’t much change in healthcare hiring in September.